Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients [Phase 3]
Phase 3 trial evaluating fondaparinux sodium (GSK576428) for acute deep vein thrombosis in Japanese patients has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2010-06-09Clinical Trial Update: Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery [Phase 2, Phase 3]
This update reports the completion of Phase 2 and Phase 3 clinical trials evaluating prevention of venous thromboembolism in patients underg…
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation) [Phase 3]
Phase 3 CANBESURE study evaluating bemiparin in cancer patients undergoing surgery for venous thromboembolism has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-06Clinical Trial Update: Celect Vena Cava Filter Clinical Trial [NA]
Completed clinical trial for Celect Vena Cava Filter with results posted.
-
CLINICAL_TRIALS trial_result · 2010-03-29Clinical Trial Update: Mortality Due to Malignancy in Patients With Idiopathic Venous Thromboembolism
The clinical trial investigating mortality due to malignancy in patients with idiopathic venous thromboembolism has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: Enoxaparin in Acute Venous Thromboembolic Disease [Phase 4]
Phase 4 trial update evaluating enoxaparin for acute venous thromboembolism has completed.
-
CLINICAL_TRIALS research · 2010-02-02Clinical Trial Update: Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation [Phase 2, Phase 3]
This document provides an update on a Phase 2/3 trial comparing ATI-5923, a novel vitamin K antagonist, with warfarin for patients requiring…
-
CLINICAL_TRIALS trial_result · 2009-12-02Clinical Trial Update: Use of Oral Contraceptives (OCs) Containing Dienogest and Risk of Venous Thromboembolism
This clinical trial update examined the risk of venous thromboembolism in users of oral contraceptives containing dienogest. The study resul…
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients [Phase 2]
Phase 2 clinical trial update reporting results related to prothrombin time excursions outside the therapeutic range in otherwise stable pat…
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients [Phase 4]
Phase 4 clinical trial comparing dalteparin with unfractionated heparin for the prevention of venous thromboembolism in hospitalized acutely…
-
FDA approval · 2009-08-31FDA Approved: HEPARIN SODIUM — Original Application (Hospira, Inc.)
FDA approved an original ANDA for heparin sodium, enabling its generic commercialization by Hospira, Inc.
-
FDA approval · 2009-08-14FDA Approved: ARIXTRA — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for ARIXTRA (fondaparinux sodium) submitted by Mylan Institutional LLC.
-
CLINICAL_TRIALS research · 2009-07-13Clinical Trial Update: Epidemiology of Venous Thromboembolism
This clinical trial update reports the epidemiology of venous thromboembolism and related conditions. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2009-07-10Clinical Trial Update: Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients [Phase 3]
A Phase 3 trial evaluating fondaparinux sodium for venous thromboembolism prevention in Japanese patients undergoing abdominal surgery has c…
-
CLINICAL_TRIALS trial_result · 2009-06-03Clinical Trial Update: Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial) [Phase 2]
A Phase 2 trial by vTv Therapeutics evaluated a Factor IX inhibitor to prevent venous thromboembolism in hip fracture patients; the study st…
-
CLINICAL_TRIALS trial_result · 2009-05-08Clinical Trial Update: Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement [Phase 2]
A Phase 2 dose-ranging study evaluating BAY 59-7939 (rivaroxaban) for prevention of venous thromboembolism in patients undergoing elective t…
-
CLINICAL_TRIALS trial_result · 2008-12-18Clinical Trial Update: Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients
Notes the completion of a clinical trial evaluating venous thromboembolism prophylaxis in medically ill patients (sponsored by University of…
-
CLINICAL_TRIALS trial_result · 2008-12-10Clinical Trial Update: Dose Ranging Study in Elective Total Hip Replacement Surgery [Phase 2, Phase 3]
A dose-ranging Phase 2/Phase 3 trial in elective total hip replacement surgery evaluated prevention of venous thromboembolism, and the study…
-
CLINICAL_TRIALS trial_result · 2008-12-01Clinical Trial Update: 12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China [Phase 4]
Phase 4 clinical trial comparing 12-hour and 2-hour urokinase regimens for pulmonary embolism in China has completed.
-
CLINICAL_TRIALS trial_result · 2008-11-24Clinical Trial Update: Nadroparin for the Initial Treatment of Pulmonary Thromboembolism [Phase 4]
A Phase 4 trial evaluating nadroparin for the initial treatment of pulmonary embolism has completed.
-
CLINICAL_TRIALS trial_result · 2008-10-20Clinical Trial Update: Comparative Study Between Thrombosis Prophylaxis Protocols
This completed clinical trial compares thrombosis prophylaxis protocols for preventing deep vein thrombosis. The study is sponsored by UPECL…
-
FDA approval · 2008-10-17FDA Approved: ARIXTRA — Supplemental Application (Mylan Institutional LLC)
The FDA approved a supplemental application for ARIXTRA (fondaparinux sodium) filed by Mylan Institutional LLC. The approval updates the exi…
-
CLINICAL_TRIALS trial_result · 2008-09-29Clinical Trial Update: Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Study [Phase 4]
Pfizer's Phase 4 pilot study evaluating dalteparin for prophylaxis of venous thromboembolism in primary care was terminated.
-
CLINICAL_TRIALS research · 2008-06-13Clinical Trial Update: Screening for Occult Malignancy in Idiopathic Venous Thromboembolism [NA]
The ClinicalTrials.gov entry for NCT00361647 indicates completion of a study on screening for occult malignancy in idiopathic venous thrombo…
-
CLINICAL_TRIALS trial_result · 2008-06-03Clinical Trial Update: Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis [Phase 4]
A Phase 4 trial comparing long-term low-molecular-weight heparin with oral anticoagulants for venous thromboembolism, including deep vein th…